Characterization of a mobile Stat6 activation motif in the human IL-4 receptor

被引:0
|
作者
Ryan, JJ [1 ]
McReynolds, LJ [1 ]
Huang, H [1 ]
Nelms, K [1 ]
Paul, WE [1 ]
机构
[1] NIAID, Immunol Lab, Bethesda, MD 20892 USA
来源
JOURNAL OF IMMUNOLOGY | 1998年 / 161卷 / 04期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The IL-4R induces proliferation and gene expression through the use of conserved tyrosine residues located in growth and gene regulation domains, respectively. We demonstrate that residues surrounding these conserved tyrosines (juxtatyrosine residues) are essential for the proper activation of the signaling molecules IRS-2 and Stat6, as well as for IL-4-induced gene expression. Further, we found that the IL-4R gene regulation domain (amino acids 557-657) contains a tyrosine-based sequence (EAGYKAF) that can convey Stat6 DNA binding and gene expression activities to a minimally active IL-4R mutant, Delta 557. Thus, this tyrosine-based sequence can function as a mobile Stat6 activation cassette. However, mutants bearing this sequence induced CD23 expression much less efficiently than did wild-type IL-4R, requiring 150-fold more IL-4 to reach maximal CD23 expression. Our results indicate the importance of juxtatyrosine residues in IL-4R signaling and argue for an essential role of extended domain structure in the recognition and function of juxtatyrosine sequences.
引用
收藏
页码:1811 / 1821
页数:11
相关论文
共 50 条
  • [21] Type-I and type-II interferons inhibit activation of STAT6 by IL-4 and IL-13 in human monocytes
    Dickensheets, HL
    Donnelly, RP
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 32 - 32
  • [22] Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis
    Singh, RR
    Saxena, V
    Zang, S
    Li, L
    Finkelman, FD
    Witte, DP
    Jacob, CO
    JOURNAL OF IMMUNOLOGY, 2003, 170 (09): : 4818 - 4825
  • [23] Unexpected phenotype of STAT6 heterozygous mice implies distinct STAT6 dosage requirements for different IL-4 functions
    Buegis, Susanne
    Gessner, Andre
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2007, 143 (04) : 263 - 268
  • [24] IL-4 preferentially activates a novel STAT6 isoform in mast cells
    Sherman, MA
    Secor, VH
    Brown, MA
    JOURNAL OF IMMUNOLOGY, 1999, 162 (05): : 2703 - 2708
  • [25] The role of IL-4/STAT6 signalling in regulation of adipocytes glucose metabolism
    Michurina, S.
    Stafeev, I.
    Arfanyan, A.
    Beloglazova, I.
    Shevchenko, E.
    Menshikov, M.
    Parfyonova, Y.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S221 - S221
  • [26] IL-13, IL-4 receptor α chain (IL-4Rα), and Stat6, but not IL-4, are required to expel the GI nematode parasite Nippostrongylus brasiliensis.
    Finkelman, FD
    Noben-Trauth, N
    Donaldson, DD
    Madden, KB
    Morris, SC
    Collins, M
    Urban, JF
    FASEB JOURNAL, 1998, 12 (04): : A569 - A569
  • [27] Regulation of IL-4-induced STAT6 activation by SUMOylation
    Lee, Choong-Eun
    Tran, Tam
    Kim, Seol-Hee
    Sung, Ki-Sa
    Choi, Cheol-Yong
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [28] Type-I and type-II interferons inhibit activation of STAT6 by IL-4 and IL-13 in human monocytes.
    Dickensheets, HL
    Donnelly, RP
    FASEB JOURNAL, 1999, 13 (05): : A1149 - A1149
  • [29] Progesterone-induced blocking factor activates STAT6 via binding to a novel IL-4 receptor
    Kozma, N
    Halasz, M
    Polgar, B
    Poehlmann, TG
    Markert, UR
    Palkovics, T
    Keszei, M
    Par, G
    Kiss, K
    Szeberenyi, J
    Grama, L
    Szekeres-Bartho, J
    JOURNAL OF IMMUNOLOGY, 2006, 176 (02): : 819 - 826
  • [30] INTERNALIZATION OF HUMAN IL-4 AND BIOCHEMICAL-CHARACTERIZATION OF THE HUMAN IL-4 RECEPTOR
    GALIZZI, JP
    ZUBER, C
    CABRILLAT, H
    BANCHEREAU, J
    LYMPHOKINE RESEARCH, 1988, 7 (03): : 309 - 309